| Literature DB >> 32316665 |
Mohamad Shazeli Che Zain1, Soo Yee Lee1, Murni Nazira Sarian2,3, Sharida Fakurazi2, Khozirah Shaari1.
Abstract
Oil palm (Elaeis guineensis Jacq.) leaves (OPL) are widely available at zero cost in Southeast Asia countries, especially in Malaysia and Indonesia due to large scale oil palm plantations. OPLs contain a large amount of flavonoids in particular flavonoid C-glycosides, which are known to possess useful biological properties including antioxidant and wound healing properties. The present study aimed at evaluating the wound healing efficacy of OPL in various solvent extracts and flavonoid enriched fractions and to determine the contribution of flavonoid C-glycosides (orientin, isoorientin, vitexin and isovitexin) using in-vitro scratch assay on 3T3 fibroblast cells. Solvent crude extracts with different polarity were screened and the most active extract was subjected to acid hydrolysis. The crude and acid hydrolysed extracts were further enriched using macroporous resins, XAD7HP. UHPLC-UV/PDA and LC-MS/MS analysis were applied for identification and confirmation of flavonoid C-glycosides. The wound healing properties comprised of cell viability, cell proliferation and cell migration were studied. Allantoin was used as a positive control to compare the efficacy among the tested samples. The results revealed all OPL crude extracts, flavonoid enriched fractions and flavonoid C-glycosides were non-toxic at concentrations below 25 µg/mL and showed better cell proliferation and migration activities at low concentrations than higher concentrations.. This study also demonstrated orientin, isoorientin, vitexin and isovitexin presented in OPL extracts and flavonoid enriched fractions stimulated proliferation and migration of 3T3 fibroblast cells. Hence, these findings may pose potential therapeutic bioactive agents for wound healing by enhancing fibroblast proliferation and migration.Entities:
Keywords: crude extracts; flavonoid C-glycosides; oil palm (Elaeis guineensis Jacq.) leaf; total flavonoids; wound healing
Year: 2020 PMID: 32316665 PMCID: PMC7222399 DOI: 10.3390/antiox9040326
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Graphical flow chart of various sample preparations. UAE = ultrasound assisted extraction, MAR = macroporous resin, solid arrow = pathway to obtain total flavonoid enriched fraction, dotted arrow= pathway to obtain total flavonoid C-glycosides enriched fraction.
Figure 2UHPLC-UV/PDA chromatogram of OPL crude extracts and flavonoid enriched fractions (A) hexane, (B) ethyl acetate, (C) ethyl acetate-methanol, (D) absolute methanol, (E) aqueous methanol, (F) total flavonoid enriched fraction, (G) acid hydrolysed aqueous methanolic extract and (H) total flavonoid C-glycoside enriched fraction.
Identification of flavonoid C-glycosides present in oil palm mature leaf crude extracts and flavonoid enriched fractions by LC-MS and UHPLC-UV/PDA.
| Peak | tR (min) | λmax, (nm) | [M−H]− ( | Formula | Key MS/MS Fragments ( | Compound | He | Ea | EM | Abs. Me | Aq. Me | Enriched OPL | OPLAH | Enriched OPLAH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3.17 | 272, 348 | 609.1411 | C27H30O16 | 519.1104 489.0998, 429.0786, 399.0696, 369.0585 | Luteolin-6-8-di- | + | ++ | ++ | ++ | +++ | ++++ | + | ++ |
| 2 | 4.88 | 272, 336 | 593.1464 | C27H30O15 | 503.1155, 473.1051, 383.0739, 353.0638 | Apigenin-6,8-di- | + | ++ | ++ | ++ | +++ | ++++ | + | ++ |
| 3 | 6.72 | 272, 346 | 609.1411 | C27H30O16 | 489.1001, 429.0789, 399.0679, 369.0604 | Luteolin-6-8-di- | - | + | ++ | ++ | +++ | ++++ | - | - |
| 4 | 7.10 | 272, 334 | 563.1359 | C26H28O14 | 473.1053, 443.0949, 383.0742, 353.0639 | Apigenin-6- | - | + | ++ | ++ | +++ | ++++ | - | - |
| 5 | 7.86 | 270, 348 | 447.0896 | C21H20O11 | 357.0588, 339.0480, 327.0483, 297.0379, 285.0381 | Isoorientin (Luteolin-6- | + | + | ++ | ++ | +++ | ++++ | ++ | ++++ |
| 6 | 8.52 | 272, 336 | 563.1359 | C26H28O14 | 473.1051, 443.0949, 383.0741, 353.0638 | Apigenin-6- | + | ++ | + | ++ | +++ | ++++ | + | + |
| 7 | 9.00 | 270, 350 | 447.0896 | C21H20O11 | 357.0587, 339.0476, 327.0485, 297.0378, 285.0380 | Orientin (Luteolin-8- | - | + | ++ | ++ | +++ | ++++ | + | ++++ |
| 8 | 9.87 | 270, 348 | 593.1464 | C27H30O15 | 473.1049, 429.0792, 369.0590, 357.0589, 327.0485 | Luteolin-6- | - | + | + | ++ | +++ | ++++ | - | - |
| 9 | 11.22 | 274, 334 | 563.1359 | C26H28O14 | 503.1168, 473.1056, 443.0950, 383.0743, 353.0639 | Apigenin-6- | - | + | + | + | ++ | ++++ | - | - |
| 10 | 11.60 | 272, 336 | 593.1464 | C27H30O15 | 473.1067, 413.0846, 369.0590, 357.0589, 293.0434 | Luteolin-6- | - | + | + | ++ | +++ | ++++ | - | - |
| 11 | 12.44 | 270, 338 | 431.0947 | C21H20O10 | 341.0639, 323.0529, 311.0536, 283.0589 | Vitexin (Apigenin-6- | - | + | + | ++ | +++ | ++++ | ++ | ++++ |
| 12 | 13.85 | 270, 338 | 431.0947 | C21H20O10 | 341.0638, 323.0536, 311.0536, 283.0588 | Isovitexin (Apigenin-8- | - | + | ++ | ++ | +++ | ++++ | ++ | ++++ |
| 13 | 17.19 | 270, 338 | 577.1306 | C27H30O14 | 457.1098, 413.0845, 353.0630, 341.0640, 311.0536, 293.0432 | Apigenin-6- | - | + | + | ++ | +++ | ++++ | - | - |
He = hexane, Ea = ethyl acetate, EM = ethyl acetate-methanol, Abs. Me = absolute methanol, Aq. Me = aqueous methanol, Enriched OPL = total flavonoid enriched fraction, OPLAH = acid hydrolysed OPL extract, Enriched OPLAH = total flavonoid C-glycoside enriched fraction, (-) = trace, (+) = low concentration, (++) = medium concentration, (+++) = high concentration and (++++) = significantly high concentration.
Figure 3UHPLC-UV/PDA chromatogram of selected reference standards of flavonoid C-glycosides (isoorientin, orientin, vitexin and isovitexin).
Figure 4The effects of (A) different OPL crude extracts, (B) flavonoid enriched fractions and (C) flavonoid C-glycosides on cell viability of 3T3 fibroblast cells. At 48 h of treatment, the viability of treated cells was evaluated through mitochondrial activity using the MTT assay and calculated by comparing the values from treatment groups with the control group. Values are presented as the mean percentage ± standard deviation (n = 3) from three experiments, * p < 0.05 versus control group. OPL = aqueous methanolic extract, Enriched OPL = total flavonoid enriched fraction, OPLAH = acid hydrolysed OPL extract, Enriched OPLAH = total flavonoid C-glycoside enriched fraction.
Figure 5The effects of treatment of (A) different OPL crude extracts, (B) flavonoid enriched fractions and (C) flavonoid C-glycosides on cell proliferation of 3T3 fibroblast cells. The proliferation test was estimated by cell counting kit-8 assay and calculated by comparing the values from treatment groups with the control group. Values are presented as the mean percentage ± standard deviation (n = 3) from three individual experiments. * p < 0.05 versus control group. OPL = aqueous methanolic extract, Enriched OPL = total flavonoid enriched fraction, OPLAH = acid hydrolysed OPL extract, Enriched OPLAH = total flavonoid C-glycoside enriched fraction.
Figure 6The effects of treatment of (A) different OPL crude extracts, (B) flavonoid enriched fractions and (C) flavonoid C-glycosides on cell migration and cell proliferation assay of 3T3 fibroblast cells. The migration and proliferation effects were estimated by percentage of migration and proliferation of cell (%) by comparing the values from 0 h, 24 h and 48 h. Values are presented as the mean percentage ± standard deviation with six replications (n = 6). Negative control (24 h; 20.33% ± 6.74, 48 h; 40.35% ± 3.33). Allantoin (24 h; 61.82% ± 9.86, 48 h; 94.96% ± 1.37). OPL = aqueous methanolic extract, Enriched OPL = total flavonoid enriched fraction, OPLAH = hydrolysed aqueous methanolic extract, Enriched OPLAH = total flavonoid C-glycoside enriched fraction.
Figure 7Digital images show the effect of different OPL crude extracts, hydrolysed extract, flavonoid enriched fractions and flavonoid C-glycosides on 3T3 fibroblast migration and proliferation via scratch assay at 1.563 µg/mL. Migration and proliferation of fibroblast cells were captured and measured using light microscope attached to a digital camera. Magnification (×5).